Literature DB >> 7332613

Plasma high density lipoproteins in coronary, cerebral and peripheral vascular disease. The influence of various risk factors.

M Bihari-Varga, J Székely, E Gruber.   

Abstract

High density lipoprotein (HDL) cholesterol and the HDL/total cholesterol ratio have been measured in 440 patients with coronary, cerebral or peripheral vascular disease and in 440 matched controls. The patients were subdivided into sex- and age-groups and according to physical activity, smoking, hypertension and non-insulin-dependent and insulin-dependent diabetes mellitus. The average HDL cholesterol level was significantly decreased in all the three groups of localization of ischaemic vascular disease (IVD). Plasma HDL concentration in men was lower than in women in every age-group. Lowest values were measured in patients with cerebral vascular diseases. From among the risk factors supposed to be related to IVD, lack of physical exercise resulted in a decrease of HDL cholesterol and HDL/total cholesterol values. In all the three localizations of IVD cigarette smokers had lower HDL levels than non-smokers. The influence of hypertension on serum HDL concentration was not unidirectional. The coexistence of non-insulin-dependent diabetes and IVD resulted in decreased lipid parameters. The sera of insulin-dependent diabetics had higher HDL contents and higher HDL/total cholesterol ratios than those of non-diabetics in all the three localizations of the vascular disease in men and in women suffering from peripheral vascular disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7332613     DOI: 10.1016/0021-9150(81)90144-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

Review 1.  Lipids and the elderly.

Authors:  Wilbert S Aronow
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

Review 2.  Aetiology of peripheral atherosclerosis.

Authors:  F G Fowkes
Journal:  BMJ       Date:  1989-02-18

Review 3.  Managing hyperlipidaemia in the elderly: special considerations for a population at high risk.

Authors:  Wilbert S Aronow
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study.

Authors:  E Lindenstrøm; G Boysen; J Nyboe
Journal:  BMJ       Date:  1994-07-02

5.  Cholesterol and cardiovascular disease in the elderly. Facts and gaps.

Authors:  Francisco J Félix-Redondo; Maria Grau; Daniel Fernández-Bergés
Journal:  Aging Dis       Date:  2013-03-01       Impact factor: 6.745

Review 6.  Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders.

Authors:  J E Frampton; R N Brogden
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

7.  Lipid-lowering therapy in older persons.

Authors:  Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2015-01-08       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.